Cargando…

A nomogram combining PPARγ expression profiles and clinical factors predicts survival in patients with hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is the most common primary liver cancer with poor prognosis. Peroxisome proliferator-activated receptor γ (PPARγ) is involved in the development of various tumor types. However, its role in hepatocellular carcinoma (HCC) remains unclear. Multiple databases including Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Xiaolu, Chi, Yajing, Dong, Zhiyuan, Tao, Tao, Zhang, Xin, Pan, Wensheng, Wang, Yemeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933753/ https://www.ncbi.nlm.nih.gov/pubmed/33692851 http://dx.doi.org/10.3892/ol.2021.12581

Ejemplares similares

The Role of PPARγ in Hepatocellular Carcinoma
por: Borbath, Ivan, et al.
Publicado: (2008)

Comprehensive radiomics nomogram for predicting survival of patients with combined hepatocellular carcinoma and cholangiocarcinoma
por: Tang, You-Yin, et al.
Publicado: (2021)

A novel nomogram for predicting survival of patients with poorly differentiated gastric adenocarcinoma
por: Zhou, Xiaolu, et al.
Publicado: (2021)

Involvement of PPARγ in the antitumoral action of cannabinoids on hepatocellular carcinoma
por: Vara, D, et al.
Publicado: (2013)

USP22 regulates lipidome accumulation by stabilizing PPARγ in hepatocellular carcinoma
por: Ning, Zhen, et al.
Publicado: (2022)

γ-glutamyl transferase-to-platelet ratio based nomogram predicting overall survival of gallbladder carcinoma
por: Sun, Le-Jia, et al.
Publicado: (2020)

Construction and validation of a nomogram for predicting cancer-specific survival in hepatocellular carcinoma patients
por: Liu, Kang, et al.
Publicado: (2020)

A Novel Nomogram Model to Predict the Recurrence-Free Survival and Overall Survival of Hepatocellular Carcinoma
por: Zhang, Shu-Wen, et al.
Publicado: (2022)

Comparative Gene Expression Profiles Induced by PPARγ and PPARα/γ Agonists in Human Hepatocytes
por: Rogue, Alexandra, et al.
Publicado: (2011)

A genomic-clinical nomogram predicting recurrence-free survival for patients diagnosed with hepatocellular carcinoma
por: Kong, Junjie, et al.
Publicado: (2019)

A Prognostic Nomogram Based on Immune Scores Predicts Postoperative Survival for Patients with Hepatocellular Carcinoma
por: Wang, Jukun, et al.
Publicado: (2020)

Development and Validation of a nomogram for forecasting survival of alcohol related hepatocellular carcinoma patients
por: Yan, Tao, et al.
Publicado: (2022)

A Nomogram Based on Combining Clinical Features and Contrast Enhanced Ultrasound LI-RADS Improves Prediction of Microvascular Invasion in Hepatocellular Carcinoma
por: Zhou, Hang, et al.
Publicado: (2021)

Ups and downs: The PPARγ/p-PPARγ seesaw of follistatin-like 1 and integrin receptor signaling in adipogenesis
por: Fang, Dongliang, et al.
Publicado: (2021)

A genomic-clinicopathologic nomogram for predicting overall survival of hepatocellular carcinoma
por: Zhou, Kena, et al.
Publicado: (2020)

Nomograms for Predicting Hepatocellular Carcinoma Recurrence and Overall Postoperative Patient Survival
por: Ma, Lidi, et al.
Publicado: (2022)

A novel inflammation‐based nomogram system to predict survival of patients with hepatocellular carcinoma
por: Chen, Jinbin, et al.
Publicado: (2018)

Integrated nomograms to predict overall survival and recurrence-free survival in patients with combined hepatocellular cholangiocarcinoma (cHCC) after liver resection
por: Wang, Tao, et al.
Publicado: (2020)

PPARγ activation reduces ischemia/reperfusion-induced metastasis in a murine model of hepatocellular carcinoma
por: LIU, YI, et al.
Publicado: (2016)

PPARγ in Neuroblastoma
por: Peri, Alessandro, et al.
Publicado: (2008)

Nomograms Predict Survival in Patients with Anaplastic Thyroid Carcinoma
por: Qiu, Bei, et al.
Publicado: (2019)

Synergistic Antiproliferative Effects of Combined γ-Tocotrienol and PPARγ Antagonist Treatment Are Mediated through PPARγ-Independent Mechanisms in Breast Cancer Cells
por: Malaviya, Abhita, et al.
Publicado: (2014)

Emerging PPARγ-Independent Role of PPARγ Ligands in Lung Diseases
por: Kulkarni, Ajit A., et al.
Publicado: (2012)

Nomograms to Predict the Disease-free Survival and Overall Survival after Radiofrequency Ablation for Hepatocellular Carcinoma
por: Takuma, Yoshitaka, et al.
Publicado: (2017)

A Simple-to-Use Nomogram for Predicting the Survival of Early Hepatocellular Carcinoma Patients
por: Chen, Si-Hai, et al.
Publicado: (2019)

Nomograms to Predict the Individual Survival of Patients with Solitary Hepatocellular Carcinoma after Hepatectomy
por: Shen, Junyi, et al.
Publicado: (2017)

Predicting the survival rate of patients with hepatocellular carcinoma after thermal ablation by nomograms
por: Zhou, Yan, et al.
Publicado: (2020)

lncRNA Ftx promotes aerobic glycolysis and tumor progression through the PPARγ pathway in hepatocellular carcinoma
por: Li, Xiao, et al.
Publicado: (2018)

Phosphorylation of PPARγ at Ser84 promotes glycolysis and cell proliferation in hepatocellular carcinoma by targeting PFKFB4
por: Shu, Yuxin, et al.
Publicado: (2016)

Halogenated bisphenol a analogues induce PPARγ-independent toxicity within human hepatocellular carcinoma cells
por: Cheng, Vanessa, et al.
Publicado: (2022)

A Nomogram Integrating Ferroptosis- and Immune-Related Biomarkers for Prediction of Overall Survival in Lung Adenocarcinoma
por: Chai, Mengyu, et al.
Publicado: (2021)

Comparative Molecular Profiling of the PPARα/γ Activator Aleglitazar: PPAR Selectivity, Activity and Interaction with Cofactors
por: Dietz, Michel, et al.
Publicado: (2012)

PPAR Could Contribute to the Pathogenesis of Hepatocellular Carcinoma
por: Kimura, Osamu, et al.
Publicado: (2012)

Effect of testosterone on the expression of PPARγ mRNA in PCOS patients
por: Cao, Jinghe, et al.
Publicado: (2019)

PPARγ and Apoptosis in Cancer
por: Elrod, Heath A., et al.
Publicado: (2008)

PPARγ, neuroinflammation, and disease
por: Mrak, Robert E, et al.
Publicado: (2004)

Nutraceuticals as Ligands of PPARγ
por: Penumetcha, Meera, et al.
Publicado: (2012)

PPARγ and Cognitive Performance
por: d’Angelo, Michele, et al.
Publicado: (2019)

Prognostic factors for disease-free survival in postoperative patients with hepatocellular carcinoma and construction of a nomogram model
por: Luo, Pan-Quan, et al.
Publicado: (2022)

Phosphorylation of PPARγ Affects the Collective Motions of the PPARγ-RXRα-DNA Complex
por: Lemkul, Justin A., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_sg1qnnanvmdigcbbbd1j3qg002